[go: up one dir, main page]

EE200300024A - Meetod 2-(6-asendatud-1,3-dioksaan-4-üül)etaanhappe derivaadi valmistamiseks, lähteühend ning lõppsaadused - Google Patents

Meetod 2-(6-asendatud-1,3-dioksaan-4-üül)etaanhappe derivaadi valmistamiseks, lähteühend ning lõppsaadused

Info

Publication number
EE200300024A
EE200300024A EEP200300024A EEP200300024A EE200300024A EE 200300024 A EE200300024 A EE 200300024A EE P200300024 A EEP200300024 A EE P200300024A EE P200300024 A EEP200300024 A EE P200300024A EE 200300024 A EE200300024 A EE 200300024A
Authority
EE
Estonia
Prior art keywords
substituted
preparation
acetic acid
formula
group
Prior art date
Application number
EEP200300024A
Other languages
English (en)
Estonian (et)
Inventor
Hermanus Mattheus Hero Kooistra Jacob
Josephus Marie Zeegers Hubertus
Mink Daniel
Maria Cornelis Antonius Mulders Joannes
Original Assignee
Dsm N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm N.V. filed Critical Dsm N.V.
Publication of EE200300024A publication Critical patent/EE200300024A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
EEP200300024A 2000-07-19 2001-07-12 Meetod 2-(6-asendatud-1,3-dioksaan-4-üül)etaanhappe derivaadi valmistamiseks, lähteühend ning lõppsaadused EE200300024A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1015744A NL1015744C2 (nl) 2000-07-19 2000-07-19 Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
PCT/NL2001/000535 WO2002006266A1 (fr) 2000-07-19 2001-07-12 Procede de preparation de derives d'acide 2-(1,3-dioxane-4-yl substitue en 6)acetique

Publications (1)

Publication Number Publication Date
EE200300024A true EE200300024A (et) 2004-10-15

Family

ID=19771761

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300024A EE200300024A (et) 2000-07-19 2001-07-12 Meetod 2-(6-asendatud-1,3-dioksaan-4-üül)etaanhappe derivaadi valmistamiseks, lähteühend ning lõppsaadused

Country Status (29)

Country Link
US (4) US6870059B2 (fr)
EP (2) EP1317440B1 (fr)
JP (2) JP5006499B2 (fr)
KR (3) KR100865016B1 (fr)
CN (3) CN100378091C (fr)
AT (1) ATE340790T1 (fr)
AU (2) AU7583001A (fr)
BR (1) BR0112535A (fr)
CA (1) CA2415963C (fr)
CY (1) CY1105881T1 (fr)
CZ (1) CZ302718B6 (fr)
DE (1) DE60123444T2 (fr)
DK (1) DK1317440T3 (fr)
EE (1) EE200300024A (fr)
ES (2) ES2387313T3 (fr)
HU (1) HUP0303166A3 (fr)
IL (3) IL153980A0 (fr)
IS (2) IS2386B (fr)
MX (1) MXPA03000498A (fr)
NL (1) NL1015744C2 (fr)
NO (1) NO328935B1 (fr)
NZ (1) NZ523703A (fr)
PL (1) PL207115B1 (fr)
PT (1) PT1317440E (fr)
RU (1) RU2266903C2 (fr)
SK (2) SK287756B6 (fr)
UA (1) UA77944C2 (fr)
WO (1) WO2002006266A1 (fr)
ZA (1) ZA200300478B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
KR100888408B1 (ko) 2001-07-13 2009-03-13 아스트라제네카 유케이 리미티드 아미노피리미딘 화합물의 제조 방법
EP1323717A1 (fr) * 2001-12-27 2003-07-02 Dsm N.V. Procédé de Préparation de Dérivés de l'acide 2-(1,3-dioxane-4-yl substitué en 6) acétique
EP1375493A1 (fr) * 2002-06-17 2004-01-02 Dsm N.V. Procédé de fabrication d'un ester d'acide acétique de dioxane
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
JP2006512086A (ja) 2002-09-20 2006-04-13 ダイヴァーサ コーポレイション スタチンおよびスタチン中間体の合成のための酵素化学的方法
US9740817B1 (en) 2002-10-18 2017-08-22 Dennis Sunga Fernandez Apparatus for biological sensing and alerting of pharmaco-genomic mutation
ATE448209T1 (de) 2002-12-16 2009-11-15 Astrazeneca Uk Ltd Verfahren zur herstellung von pyrimidinverbindungen
SI1620423T1 (sl) * 2003-05-02 2008-06-30 Dsm Ip Assets Bv Postopek za pripravo (4-hidroksi-6-okso-tetrahidro-piran-2-il)-aceetonitrila in njihovih derivatov
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
US8346482B2 (en) 2003-08-22 2013-01-01 Fernandez Dennis S Integrated biosensor and simulation system for diagnosis and therapy
UY28501A1 (es) * 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) * 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) * 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
DE10352659B4 (de) * 2003-11-11 2007-09-13 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen und Tetrahydropyranonderivate zur Verwendung in dem Verfahren
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
US7264743B2 (en) * 2006-01-23 2007-09-04 Lam Research Corporation Fin structure formation
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
WO2010118757A1 (fr) * 2009-04-15 2010-10-21 Pharmathen S.A. Procédé amélioré de préparation de fluvastatine et de sels de celle-ci
GB2482525A (en) * 2010-08-05 2012-02-08 Phoenix Chemicals Ltd A process for the production of acyloxymethyldioxanylacetic derivatives
CN103153976B (zh) 2010-09-09 2015-07-08 中化帝斯曼制药有限公司荷兰公司 7-氨基-3,5-二羟基庚酸酯的盐
EP2616454B1 (fr) 2010-09-16 2015-04-15 DSM Sinochem Pharmaceuticals Netherlands B.V. Esters d'acides hexanoïques comme intermédiaires pour la préparation d'atorvastatine
SI2665722T1 (sl) 2011-01-18 2016-12-30 Dsm Sinochem Pharmaceuticals Netherlands B.V. Postopek priprave diol sulfonov
WO2012098049A1 (fr) 2011-01-18 2012-07-26 Dsm Sinochem Pharmaceuticals Netherlands B.V. Procédé de préparation de statines en présence d'une base
CN103313984B (zh) 2011-01-18 2016-01-13 中化帝斯曼制药有限公司荷兰公司 甲基四唑硫化物和砜
CN103987705B (zh) * 2011-12-09 2015-09-30 中化帝斯曼制药有限公司荷兰公司 制备他汀含硫前体的方法
HK1201062A1 (en) 2011-12-09 2015-08-21 中化帝斯曼制药有限公司荷兰公司 Process for the preparation of a statin precursor
JP6065862B2 (ja) * 2013-04-10 2017-01-25 信越化学工業株式会社 パターン形成方法、レジスト組成物、高分子化合物及び単量体
WO2014203045A1 (fr) 2013-06-20 2014-12-24 Lupin Limited Nouveau procédé écologique et économique pour la synthèse de tert-butyl (3r,5s)-6-oxo-3,5-dihydroxy-3,5-o-isopropylidène-hexanoate
CN105624127B (zh) * 2014-10-28 2019-07-26 上海弈柯莱生物医药科技有限公司 一种葡萄糖脱氢酶及其在合成他汀类药物中间体中的应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544390A (en) * 1895-08-13 Chimney-cowl
GB885516A (en) 1958-01-16 1961-12-28 Arthur Henry Clarkson Higher fatty acid esters of dextran
US3325466A (en) 1961-01-11 1967-06-13 American Cyanamid Co Tertiary butyl group as a carboxyl protecting group in the synthesis of peptides
US3992432A (en) * 1967-04-05 1976-11-16 Continental Oil Company Phase transfer catalysis of heterogeneous reactions by quaternary salts
DE3929913A1 (de) * 1989-09-08 1991-04-04 Hoechst Ag 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte
GB9005966D0 (en) * 1990-03-16 1990-05-09 May & Baker Ltd New compositions of matter
CA2048716A1 (fr) * 1990-08-17 1992-02-18 William B. Mattingly, Iii Articles en materiau absorbant avec partie adhesive et procede de fabrication correspondant
US5292891A (en) * 1991-02-21 1994-03-08 Chisso Corporation Optically active 2,2-dimethyl-1,3-dioxin-4-ones and method for preparing same and method for preparing optically active compound for synthesis of physiologically active substance and optically active intermediate compound
JP3097143B2 (ja) 1991-02-21 2000-10-10 チッソ株式会社 生理活性物質合成用光学活性化合物の製造法および光学活性中間体化合物
JP3333197B2 (ja) * 1991-09-20 2002-10-07 アヴェシア リミテッド ピラノン
WO1993008823A1 (fr) * 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Composes de guanidinyle et composes apparentes modulant l'adhesion cellulaire
US5278313A (en) 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
US5449793A (en) * 1993-06-04 1995-09-12 Chisso Corporation Process for producing an optically active 1,5-disubstituted-2,4-O-isopropylidene-2,4-dihydroxypentane
US5795749A (en) 1995-04-05 1998-08-18 The Scripps Research Institution Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives
GB9523924D0 (en) 1995-11-23 1996-01-24 Zeneca Ltd Production of optically active 2-substituted tetrahydropyran-4-ones
FR2741620B1 (fr) * 1995-11-28 1997-12-26 Oreal Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline
US6278001B1 (en) 1995-11-28 2001-08-21 L'oréal Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping
CA2329893A1 (fr) 1998-04-30 1999-11-11 Kaneka Corporation Procede de production de derives d'acide acetique 6-cyanomethyl-1,3-dioxane-4
ES2294236T3 (es) * 1998-08-05 2008-04-01 Kaneka Corporation Procedimiento para la preparacion de esteres sustituidos con 3,5-dihidroxi como intermedios para producir derivados de acido 2-(6-hiximetil)-1,3-dioxan-4-il) acetico opticamente activos.
AU1683000A (en) 1998-12-10 2000-06-26 Kaneka Corporation Process for producing simvastatin
GB9903472D0 (en) 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
HU227840B1 (en) 1999-05-06 2012-05-02 Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag Intermediates of atorvastatin synthesis and process for producing them
KR20010072175A (ko) 1999-06-04 2001-07-31 후루타 타케시 5-히드록시-3-옥소펜탄산 유도체 제조방법
WO2001072706A1 (fr) * 2000-03-28 2001-10-04 Biocon India Limited Synthese de l'acide [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoique sous forme de sel hemi-calcique (atorvastatine)
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
DE60124907D1 (de) * 2000-06-05 2007-01-11 Kaneka Corp VERFAHREN FÜR DIE HERSTELLUNG VON OPTISCH AKTIVEN 2-i6-(HYDROXYMETHYL)-1,3-DIOXAN-4-YLöESSIGSÄURE-DERIVATEN (19.12.01)
NL1015744C2 (nl) 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
KR100888408B1 (ko) 2001-07-13 2009-03-13 아스트라제네카 유케이 리미티드 아미노피리미딘 화합물의 제조 방법
EP1323717A1 (fr) 2001-12-27 2003-07-02 Dsm N.V. Procédé de Préparation de Dérivés de l'acide 2-(1,3-dioxane-4-yl substitué en 6) acétique
KR100598079B1 (ko) 2002-02-25 2006-07-07 바이오콘 리미티드 신규의 보로네이트 에스테르
KR100511533B1 (ko) 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
EP1375493A1 (fr) 2002-06-17 2004-01-02 Dsm N.V. Procédé de fabrication d'un ester d'acide acétique de dioxane
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
ATE448209T1 (de) 2002-12-16 2009-11-15 Astrazeneca Uk Ltd Verfahren zur herstellung von pyrimidinverbindungen
WO2004103977A2 (fr) 2003-05-21 2004-12-02 Ciba Specialty Chemicals Holding Inc. Procede de preparation de derives de pyrimidine
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
WO2004113314A1 (fr) 2003-06-23 2004-12-29 Biocon Limited Nouveaux esters de boronate
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
JP4037900B2 (ja) 2003-12-24 2008-01-23 テバ ファーマシューティカル インダストリーズ リミティド Ａｎｔｉに対するｓｙｎ比率が高いスタチンの製造方法
JP4266879B2 (ja) 2004-05-12 2009-05-20 大阪瓦斯株式会社 ガス化炉及び複合リサイクル装置
US7161004B2 (en) 2004-06-21 2007-01-09 Dr. Reddy's Laboratories Limited Processes to produce intermediates for rosuvastatin
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
TW200831469A (en) 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process

Also Published As

Publication number Publication date
ES2387313T3 (es) 2012-09-20
CN101081842A (zh) 2007-12-05
IS2386B (is) 2008-07-15
IS8690A (is) 2007-11-15
KR20070121063A (ko) 2007-12-26
SK352003A3 (en) 2003-05-02
EP1700854B1 (fr) 2012-05-23
HUP0303166A2 (hu) 2003-12-29
SK287756B6 (sk) 2011-08-04
KR20080078925A (ko) 2008-08-28
US7642363B2 (en) 2010-01-05
EP1700854A1 (fr) 2006-09-13
AU2001275830B2 (en) 2006-07-20
HUP0303166A3 (en) 2005-11-28
JP2004504315A (ja) 2004-02-12
EP1317440A1 (fr) 2003-06-11
CN101081842B (zh) 2012-01-04
US20050148785A1 (en) 2005-07-07
IL177824A0 (en) 2006-12-31
NO20030025L (no) 2003-01-03
AU7583001A (en) 2002-01-30
CA2415963A1 (fr) 2002-01-24
CN1680363A (zh) 2005-10-12
JP2012111757A (ja) 2012-06-14
EP1317440B1 (fr) 2006-09-27
US20110251406A1 (en) 2011-10-13
CY1105881T1 (el) 2011-02-02
ATE340790T1 (de) 2006-10-15
KR20030040224A (ko) 2003-05-22
CN100378091C (zh) 2008-04-02
PT1317440E (pt) 2007-01-31
NO328935B1 (no) 2010-06-21
DE60123444T2 (de) 2007-08-23
CZ302718B6 (cs) 2011-09-21
PL359332A1 (en) 2004-08-23
UA77944C2 (en) 2007-02-15
NL1015744C2 (nl) 2002-01-22
CZ2003163A3 (cs) 2003-05-14
KR100865016B1 (ko) 2008-10-23
US20030158426A1 (en) 2003-08-21
NZ523703A (en) 2004-08-27
DK1317440T3 (da) 2007-01-08
CN1443183A (zh) 2003-09-17
ZA200300478B (en) 2004-01-26
RU2266903C2 (ru) 2005-12-27
IL153980A0 (en) 2003-07-31
US6870059B2 (en) 2005-03-22
US7989643B2 (en) 2011-08-02
DE60123444D1 (de) 2006-11-09
HK1097260A1 (en) 2007-06-22
IS6680A (is) 2003-01-15
US20100136339A1 (en) 2010-06-03
WO2002006266A1 (fr) 2002-01-24
SK287755B6 (sk) 2011-08-04
MXPA03000498A (es) 2003-06-24
CA2415963C (fr) 2008-02-26
JP5006499B2 (ja) 2012-08-22
ES2272506T3 (es) 2007-05-01
NO20030025D0 (no) 2003-01-03
PL207115B1 (pl) 2010-11-30
BR0112535A (pt) 2003-07-01
IL153980A (en) 2006-10-05

Similar Documents

Publication Publication Date Title
EE200300024A (et) Meetod 2-(6-asendatud-1,3-dioksaan-4-üül)etaanhappe derivaadi valmistamiseks, lähteühend ning lõppsaadused
RU2003104825A (ru) Способ получения производных 2-(6-замещенной-1, 3-диоксан-4-ил) укусной кислоты
IL222041A (en) Method for Preparing 2-Cyclopropyl and 2-Phenyl 1,6-Dihydro-6-Oxo-4-Pyrimidine Selected Carboxylic Acids and Intermediates
BR0109048A (pt) Processo para a sìntese de citalopram
JPS61118366A (ja) ２−メチルジヒドロピリジン誘導体の中間体
DK1515962T3 (da) Fremgangsmåde til fremstilling af dioxaneddikesyreestere
US4550191A (en) Process for preparing esters of 2'-(6'-methoxy-2-naphthyl)-propionic acid
KR970701711A (ko) 농업용으로 유용한 화학적 중간체(chemical intermediates useful in agriculture)
WO2002024625A3 (fr) Procede ameliore pour la preparation de derives d'acide 3-aryl-2-hydroxy propanoique
ATE286870T1 (de) Verfahren zur herstellung von estern
EP1375492A4 (fr) Procede de production de derive d'ester (dioxolenon-4-yl) methyle
ATE425972T1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
FR2799462B1 (fr) Procede de preparation d'inhibiteurs cox-2
PL326563A1 (en) Method of obtaining derivatives of methoxyiminophenyglyoxalic acid
SK280170B6 (sk) Spôsob výroby alkylesterov tetronovej kyseliny
ATE245136T1 (de) Verfahren zum herstellen eines tert-alkylesters einer carbonsäure
SE8302158D0 (sv) Verfahren zur herstellung von 1-alkyl-5-aroyl-pyrrol-2-essigseure-derivaten
DE69906009D1 (de) Verfahren zur Herstellung von 2-Alkyliden-4-Bromacetessigsäureestern
KR970010737A (ko) 2-(4-아세틸아미노벤조일아미노)벤즈아미드 유도체, 그 제조방법 및 그를 함유하는 진통제
KR910018345A (ko) 치환 및 비치환 n-히드록시-2-아미노부탄 이산 유도체 및 퀴놀린 유도체의 제조방법